Statement of Ownership (sc 13g)
24 September 2021 - 6:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Biostage, Inc.
(Name of issuer)
Common Stock, par value $0.01 per share
(Title of class of securities)
09074M 202
(CUSIP number)
September 1, 2021
(Date of event which requires filing of this
statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover
page.
The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other provisions of the Act.
|
CUSIP No. 09074M 202
|
13G
|
Page 1 of 5
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of reporting persons
An Zhang
|
|
2
|
|
Check the appropriate box if a member of a group (See Instructions)
(a) ¨ (b) ¨
|
|
3
|
|
SEC use only
|
|
4
|
|
Citizenship or place of organization
China
|
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
5
|
|
Sole voting power
650,000 shares of common stock
250,000 shares of common stock issuable upon exercise of warrants
(See Item 4)*
|
|
|
6
|
|
Shared voting power
None
|
|
|
7
|
|
Sole dispositive power
650,000 shares of common stock
250,000 shares of common stock issuable upon exercise of warrants
(See Item 4)*
|
|
|
8
|
|
Shared dispositive power
None
|
|
9
|
|
Aggregate amount beneficially owned by each reporting person
650,000 shares of common stock
250,000 shares of common stock issuable upon exercise of warrants
(See Item 4)*
|
|
10
|
|
Check box if the aggregate amount in Row (9) excludes certain shares ¨
|
|
11
|
|
Percent of class represented by amount in Row 9
6.08% (See Item 4)*
|
|
12
|
|
Type of reporting person*
IN
|
* Based upon 10,688,407 shares of the Issuer’s common stock outstanding
as of September 1, 2021. As more fully described in Item 4, the warrants are subject to a 4.99% blocker, and the percentage set forth
in row (11) gives effect to such blockers. However, as more fully described in Item 4, the securities reported in rows (5), (7) and (9)
show the number of shares of Common Stock that would be issuable upon full exercise of such reported securities and do not give effect
to such blockers. Therefore, the actual number of shares of common stock beneficially owned by such Reporting Person, after giving effect
to such blockers, is less than the number of securities reported in rows (5), (7) and (9).
|
CUSIP No. 09074M 202
|
13G
|
Page 2 of 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
|
(a)
|
|
Name of Issuer.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biostage, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b)
|
|
Address of Issuer’s Principal Executive Offices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
84 October Hill Road
Holliston, Massachusetts 01746
|
|
|
|
|
|
|
|
|
|
|
|
Item 2.
|
|
(a)
|
|
Name of Person Filing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
An Zhang
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b)
|
|
Address of Principal Business Office or, if none, Residence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
c/o Biostage, Inc., 84 October Hill Road, Suite 11, Holliston, MA 01746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c)
|
|
Citizenship
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d)
|
|
Title of Class of Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, par value $0.01 per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(e)
|
|
CUSIP Number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09074M 202
|
|
|
|
|
|
|
|
|
|
Item 3.
|
|
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
|
|
|
|
|
|
|
Not applicable
|
|
|
|
|
|
|
|
|
(a)
|
|
¨
|
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
|
|
|
(b)
|
|
¨
|
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
|
|
(c)
|
|
¨
|
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
|
|
(d)
|
|
¨
|
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
|
|
|
(e)
|
|
¨
|
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
|
|
|
(f)
|
|
¨
|
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
|
|
|
(g)
|
|
¨
|
|
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
|
|
|
(h)
|
|
¨
|
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
|
|
|
(i)
|
|
¨
|
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
|
|
|
|
|
|
|
(j)
|
|
¨
|
|
A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
|
|
|
|
|
|
|
|
|
|
|
|
(k)
|
|
¨
|
|
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
CUSIP No. 09074M 202
|
13G
|
Page 3 of 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 4.
|
|
Ownership
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
Amount beneficially owned:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650,000 shares of common stock
250,000 shares of common stock issuable upon exercise of warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b)
|
|
Percent of class:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.08%.
The percentage of outstanding common stock that may be deemed to be
beneficially owned by the Reporting Person is set forth on Line 11 of the cover sheet. Such percentage was calculated based on 10,688,407
shares, which is comprised of 9,688,407 shares of Common Stock outstanding as of August 13, 2021, as reported on the Issuer’s Quarterly
Report on Form 10-Q filed with the Securities and Exchange Commission on August, 2021; 500,000 shares of Common Stock purchased by the
Reporting Person in a private placement; and 500,000 shares of Common Stock purchased by one other purchaser in such private placement.
Pursuant to the terms of the warrants held by the Reporting Person, the Reporting Person cannot exercise the warrants to the extent the
Reporting Person would beneficially own, after any such exercise, more than 4.99% of the outstanding shares of Common Stock (the “Blockers”),
and the percentage set forth in Line 11 of the cover page for each Reporting Person gives effect to the Blockers. Consequently,
as of the date of the event which requires the filing of this statement, the Reporting Person was not able to exercise any of the warrants
due to the Blockers. The Reporting Person and the Issuer may agree in the future to amend the Blocker Warrants to modify or eliminate
the Blockers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c)
|
|
Number of shares as to which the person has:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
|
Sole power to vote or to direct the vote:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650,000 shares of common stock
250,000 shares of common stock issuable upon exercise of warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii)
|
|
Shared power to vote to direct the vote:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii)
|
|
Sole power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650,000 shares of common stock
250,000 shares of common stock issuable upon exercise of warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iv)
|
|
Shared power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None
|
|
|
|
|
|
|
|
|
|
Item 5.
|
|
Ownership of Five Percent or Less of a Class
|
|
|
|
|
|
|
|
|
|
Not applicable
|
|
|
|
|
|
|
|
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.
|
|
|
|
|
|
|
|
|
Item 6.
|
|
Ownership of More than Five Percent on behalf of Another Person.
|
|
|
|
|
|
|
|
Not applicable
|
|
|
|
|
Item 7.
|
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
|
|
|
|
|
|
|
Not applicable
|
|
CUSIP No. 09074M 202
|
13G
|
Page 4 of 5
|
|
Item 8.
|
Identification and Classification of Members of the Group
|
|
|
|
|
|
Not applicable
|
|
|
|
|
Item 9.
|
Notice of Dissolution of Group
|
|
|
|
|
|
Not applicable
|
|
|
|
|
Item 10.
|
Certification
|
|
|
|
|
|
Not applicable
|
|
CUSIP No. 09074M 202
|
13G
|
Page 5 of 5
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and correct.
|
|
September 23, 2021
|
|
|
Date
|
|
|
|
|
|
/s/ An Zhang
|
|
|
Signature
|
|
|
|
|
|
An Zhang
|
|
|
Name/Title
|
NYLI Healthy Hearts ETF (AMEX:HART)
Historical Stock Chart
From Dec 2024 to Jan 2025
NYLI Healthy Hearts ETF (AMEX:HART)
Historical Stock Chart
From Jan 2024 to Jan 2025
